Trial Profile
ComPArison of the Effect of Ticagrelor Versus Clopidogrel on Myocardial Blood Flow (MBF) and Reserve (MBFR) Measured With Positron Emission TomograpHy (PET) in Patients With Coronary Artery Disease (CAD): The PATH Study
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Therapeutic Use
- Acronyms PATH
- 23 Nov 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Mar 2015 Planned primary completion date changed from 1 Jan 2015 to 1 Mar 2015, as reported by ClinicalTrials.gov.
- 03 Mar 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.